Endoluminal radiofrequency ablation with SpyGlass ™ in the management of cholangiocarcinoma: a case report.

Endoluminal radiofrequency ablation with SpyGlass™ in the management of cholangiocarcinoma: a case report. Rev Esp Enferm Dig. 2019 Jul 29;111: Authors: Mansilla-Vivar R, Argüello-Viúdez L, Sánchez-Montes C, Alonso-Lázaro N, Pons-Beltrán V Abstract Most extrahepatic cholangiocarcinomas are unresectable at the time of diagnosis and even in case of a resectable cancer, surgery is not an option for the elderly or patients with comorbidities (1). Current treatment alternatives in these scenarios are very limited. Biliary stenting with self-expanding metal stents (SEMS) is the mainstay palliative treatment for biliary obstruction (2). However, emerging experience with endoscopic RF ablation (RFA) in this setting has been reported in the literature. PMID: 31353916 [PubMed - as supplied by publisher]
Source: Revista Espanola de Enfermedades Digestivas - Category: Gastroenterology Tags: Rev Esp Enferm Dig Source Type: research